top of page
Home
Areas of Expertise
About
Publications
CONTACT
Generics substitution, bioequivalence standards, and international oversight: complex issues facing the FDA
Trends in Pharmacological Sciences
37(3):184-191
Next Item
Previous Item
Home
Areas of Expertise
About
Publications
bottom of page